The Minnesota Center for Chemical and Mental Health invites you to view online or in person, its second Friday Webinars. MNCAMH draws from experts in their respective fields and asks them to provide a one hour lecture related to their area of interest with a focus on application to practice. One CEU is available for those who attend this webinar in person or live on the web, complete an evaluation of the webinar and pass a post test based on the material presented. Evaluation and post test are available immediately following the webinar.
The webinar is broadcast from room 145 Peters Hall in the University of Minnesota School of Social Work, 1404 Gortner Avenue, St. Paul 55108. Parking is available in the Gortner Avenue Ramp directly across the street from Peters Hall. All webinars take place between Noon and 1PM.
We are now using GoToWebinar for our online delivery. This webinar can be viewed on a smart phone or tablet by downloading the GoToMeeting app from the Apple Store or the Android app. To register for the September Webinar click on the following link: Register
Notice! This webinar will be broadcast from 11:30am - 12:30pm rather than the usual Noon - 1pm.
Cigarette smoking is the leading preventable cause of premature death in the United States, with the most recent Surgeon General’s report estimating that approximately 480,000 deaths in the United States annually can be attributed to smoking. Although the majority of smokers indicate an interest in quitting smoking, long term-cessation rates remain low. Proper use of medication however can more than double success rates. Dr. Kotlyar is an Associate Professor in the Department of Experimental and Clinical Pharmacology in the College of Pharmacy. His research interests focus on pharmacologic treatment for tobacco dependence. This webinar will review the pharmacotherapies currently available to assist with the smoking cessation attempt focusing on their efficacy, proper use and side effects.
Ken Winters, PhD
University of Minnesota Department of Psychiatry
Marijuana is the most commonly used “illicit” drug in the United States. Approximately 12% of individuals 12 years of age or older reported using this drug in 2013, and rates are higher among the younger age groups (Center for Behavioral Health Statistics and Quality, 2013). More Americans now perceive that marijuana is harmless than view it as harmful (Pew Research Center, 2013), and many believe that it should be legal and unregulated. Currently, 22 states either allow medical or recreational use of the drug. As policy shifts toward medicalization and legalization of marijuana, it is reasonable to expect that prevalence rates and resulting health consequences will increase. Use of marijuana has been linked to negative health effects, but the evidence varies as a function of age of user, whether use is recreational or regular, and health domain (Volkow et al., 2014). For example, the evidence is stronger of the drug’s deleterious effects when use occurs among teenagers. This relatively emerging science pertaining to marijuana use and adolescents, and clinical implications, will be reviewed in this webinar.
Provider Preparedness for Treatment of Co-occurring Disorders: Comparison of Social Workers and Alcohol and Drug Counselors
Colleen M. Fisher, Jennifer Simmelink McCleary, Peter Dimock & Julie Rohovit
Published online: in Social Work Education: The International Journal, June 11, 2014. Click here for link to article
Dr. Michael Kotlyar
Dr. Ken Winters
The Minnesota Center of Excellence in Mental and Chemical Health strives to advance the science and practice of treating mental health and substance abuse disorders through research and dissemination of clinical best practices and develops advancements in professional and degree-based education for providers.
MNCAMH is sponsored by funds from the Minnesota Department of Human Services Adult Mental Health Division.